This strategic acquisition combines BioCentric’s medical affairs and commercial expertise with JPA Health’s integrated services, predictive analytics and AI-driven solutions.
Tag Archive for: product pipeline
During Wednesday’s annual R&D Day, Moderna said it is culling four programs from its pipeline, including two molecules that had been discontinued last year by AstraZeneca.
The New York-based company has been pressured by declining demand for two of its top drugs, the blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition.